𝔖 Bobbio Scriptorium
✦   LIBER   ✦

On the Estimation of True Treatment Response when Patients Enter Staggeredly in a Clinical Trial

✍ Scribed by Prof. S. Biswas; Sunita Chitkara

Publisher
John Wiley and Sons
Year
1995
Tongue
English
Weight
368 KB
Volume
37
Category
Article
ISSN
0323-3847

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Estimation of the treatment effect in a
Estimation of the treatment effect in a clinical trial when recurrent events define the endpoint
✍ CΓ©dric MahΓ©; Sylvie Chevret πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 89 KB πŸ‘ 2 views

Recurrent events are frequently encountered in clinical trials when individuals may experience an event more than once. Examples are common in medical research, including infectious episodes, myocardial infarctions and hospital admissions. However, when only the "rst event is considered, there is a

An index of the three core data set pati
An index of the three core data set patient questionnaire measures distinguishes efficacy of active treatment from that of placebo as effectively as the American College of Rheumatology 20% response criteria (ACR20) or the Disease Activity Score (DAS) in a rheumatoid arthritis clinical trial
✍ T. Pincus; V. Strand; G. Koch; I. Amara; B. Crawford; F. Wolfe; S. Cohen; D. Fel πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 65 KB πŸ‘ 2 views
Tocilizumab inhibits structural joint da
Tocilizumab inhibits structural joint damage in rheumatoid arthritis patients with inadequate responses to methotrexate: Results from the double-blind treatment phase of a randomized placebo-controlled trial of tocilizumab safety and prevention of structural joint damage at one year
✍ Joel M. Kremer; Ricardo Blanco; Marek Brzosko; Ruben Burgos-Vargas; Anne-Marie H πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 233 KB πŸ‘ 2 views